| Ms Marion Lesley Patterson, MD | |
|
2171 Route 70 W, Cherry Hill, NJ 08002-2733 | |
| (856) 406-0023 | |
| Not Available |
| Full Name | Ms Marion Lesley Patterson |
|---|---|
| Gender | Female |
| Speciality | Family Practice |
| Experience | 28 Years |
| Location | 2171 Route 70 W, Cherry Hill, New Jersey |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1194878991 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 25MA06667000 (New Jersey) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Patient First Maryland Physicians Group, P.c.. | 9335391978 | 45 |
News Archive
Vocera Inc. today announced the first shipment of the Vocera smartphone, the newest addition to the Vocera system of wireless, instant communication products. The new device, in addition to supporting all of the Vocera system's unique voice-driven features, works as a wireless telephone and offers advanced application support to deliver enhanced staff efficiency and expedited patient care.
The lung clearance index (LCI) is a sensitive non-invasive marker of early lung disease in young children with cystic fibrosis (CF), according to a new study from Australian researchers.
Evotec AG today announced that it has entered into a license and collaboration agreement with Zhejiang Jingxin Pharmaceutical Co., Ltd for EVT 201, a novel potential treatment for insomnia. The agreement grants Jingxin Pharma exclusive rights to develop and market the drug candidate in China. In return, Evotec will receive a small upfront payment, together with commercial milestones and significant royalties.
The concept of patients' charters is inadequate and should be replaced with charters of health responsibilities, argues an expert in this week's British Medical Journal.
› Verified 1 days ago
| Entity Name | Medexpress Urgent Care - New Jersey Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1205183894 PECOS PAC ID: 6103076526 Enrollment ID: O20121022000045 |
News Archive
Vocera Inc. today announced the first shipment of the Vocera smartphone, the newest addition to the Vocera system of wireless, instant communication products. The new device, in addition to supporting all of the Vocera system's unique voice-driven features, works as a wireless telephone and offers advanced application support to deliver enhanced staff efficiency and expedited patient care.
The lung clearance index (LCI) is a sensitive non-invasive marker of early lung disease in young children with cystic fibrosis (CF), according to a new study from Australian researchers.
Evotec AG today announced that it has entered into a license and collaboration agreement with Zhejiang Jingxin Pharmaceutical Co., Ltd for EVT 201, a novel potential treatment for insomnia. The agreement grants Jingxin Pharma exclusive rights to develop and market the drug candidate in China. In return, Evotec will receive a small upfront payment, together with commercial milestones and significant royalties.
The concept of patients' charters is inadequate and should be replaced with charters of health responsibilities, argues an expert in this week's British Medical Journal.
› Verified 1 days ago
| Entity Name | Patient First Maryland Physicians Group, P.c.. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1982733564 PECOS PAC ID: 9335391978 Enrollment ID: O20150605001407 |
News Archive
Vocera Inc. today announced the first shipment of the Vocera smartphone, the newest addition to the Vocera system of wireless, instant communication products. The new device, in addition to supporting all of the Vocera system's unique voice-driven features, works as a wireless telephone and offers advanced application support to deliver enhanced staff efficiency and expedited patient care.
The lung clearance index (LCI) is a sensitive non-invasive marker of early lung disease in young children with cystic fibrosis (CF), according to a new study from Australian researchers.
Evotec AG today announced that it has entered into a license and collaboration agreement with Zhejiang Jingxin Pharmaceutical Co., Ltd for EVT 201, a novel potential treatment for insomnia. The agreement grants Jingxin Pharma exclusive rights to develop and market the drug candidate in China. In return, Evotec will receive a small upfront payment, together with commercial milestones and significant royalties.
The concept of patients' charters is inadequate and should be replaced with charters of health responsibilities, argues an expert in this week's British Medical Journal.
› Verified 1 days ago
| Entity Name | Prohealth Urgent Care Medicine Of New Jersey Llp |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1477927754 PECOS PAC ID: 6002178647 Enrollment ID: O20180320001992 |
News Archive
Vocera Inc. today announced the first shipment of the Vocera smartphone, the newest addition to the Vocera system of wireless, instant communication products. The new device, in addition to supporting all of the Vocera system's unique voice-driven features, works as a wireless telephone and offers advanced application support to deliver enhanced staff efficiency and expedited patient care.
The lung clearance index (LCI) is a sensitive non-invasive marker of early lung disease in young children with cystic fibrosis (CF), according to a new study from Australian researchers.
Evotec AG today announced that it has entered into a license and collaboration agreement with Zhejiang Jingxin Pharmaceutical Co., Ltd for EVT 201, a novel potential treatment for insomnia. The agreement grants Jingxin Pharma exclusive rights to develop and market the drug candidate in China. In return, Evotec will receive a small upfront payment, together with commercial milestones and significant royalties.
The concept of patients' charters is inadequate and should be replaced with charters of health responsibilities, argues an expert in this week's British Medical Journal.
› Verified 1 days ago
| Entity Name | Medexpress Urgent Care - Northern New Jersey Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1487185369 PECOS PAC ID: 4183965122 Enrollment ID: O20190401001534 |
News Archive
Vocera Inc. today announced the first shipment of the Vocera smartphone, the newest addition to the Vocera system of wireless, instant communication products. The new device, in addition to supporting all of the Vocera system's unique voice-driven features, works as a wireless telephone and offers advanced application support to deliver enhanced staff efficiency and expedited patient care.
The lung clearance index (LCI) is a sensitive non-invasive marker of early lung disease in young children with cystic fibrosis (CF), according to a new study from Australian researchers.
Evotec AG today announced that it has entered into a license and collaboration agreement with Zhejiang Jingxin Pharmaceutical Co., Ltd for EVT 201, a novel potential treatment for insomnia. The agreement grants Jingxin Pharma exclusive rights to develop and market the drug candidate in China. In return, Evotec will receive a small upfront payment, together with commercial milestones and significant royalties.
The concept of patients' charters is inadequate and should be replaced with charters of health responsibilities, argues an expert in this week's British Medical Journal.
› Verified 1 days ago
| Entity Name | Patient First New Jersey Physicians Group Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1285317750 PECOS PAC ID: 6608220322 Enrollment ID: O20230929000762 |
News Archive
Vocera Inc. today announced the first shipment of the Vocera smartphone, the newest addition to the Vocera system of wireless, instant communication products. The new device, in addition to supporting all of the Vocera system's unique voice-driven features, works as a wireless telephone and offers advanced application support to deliver enhanced staff efficiency and expedited patient care.
The lung clearance index (LCI) is a sensitive non-invasive marker of early lung disease in young children with cystic fibrosis (CF), according to a new study from Australian researchers.
Evotec AG today announced that it has entered into a license and collaboration agreement with Zhejiang Jingxin Pharmaceutical Co., Ltd for EVT 201, a novel potential treatment for insomnia. The agreement grants Jingxin Pharma exclusive rights to develop and market the drug candidate in China. In return, Evotec will receive a small upfront payment, together with commercial milestones and significant royalties.
The concept of patients' charters is inadequate and should be replaced with charters of health responsibilities, argues an expert in this week's British Medical Journal.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ms Marion Lesley Patterson, MD 101 2nd St, Lakewood, NJ 08701-3324 Ph: (732) 363-6655 | Ms Marion Lesley Patterson, MD 2171 Route 70 W, Cherry Hill, NJ 08002-2733 Ph: (856) 406-0023 |
News Archive
Vocera Inc. today announced the first shipment of the Vocera smartphone, the newest addition to the Vocera system of wireless, instant communication products. The new device, in addition to supporting all of the Vocera system's unique voice-driven features, works as a wireless telephone and offers advanced application support to deliver enhanced staff efficiency and expedited patient care.
The lung clearance index (LCI) is a sensitive non-invasive marker of early lung disease in young children with cystic fibrosis (CF), according to a new study from Australian researchers.
Evotec AG today announced that it has entered into a license and collaboration agreement with Zhejiang Jingxin Pharmaceutical Co., Ltd for EVT 201, a novel potential treatment for insomnia. The agreement grants Jingxin Pharma exclusive rights to develop and market the drug candidate in China. In return, Evotec will receive a small upfront payment, together with commercial milestones and significant royalties.
The concept of patients' charters is inadequate and should be replaced with charters of health responsibilities, argues an expert in this week's British Medical Journal.
› Verified 1 days ago
Dr. Colleen M Finan-duffy, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 36 Kresson Rd, Suite B, Cherry Hill, NJ 08034 Phone: 856-616-2444 Fax: 856-616-2376 | |
Fotini Debonera, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2339 Route 70 W, Cherry Hill, NJ 08002 Phone: 856-532-9519 | |
Dr. Cathleen M Finan, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 36 Kresson Rd, Suite B, Cherry Hill, NJ 08034 Phone: 856-616-2444 Fax: 856-616-2376 | |
William L Milligan, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 951 Haddonfield-berlin Rd, Cherry Hill, NJ 08034 Phone: 856-429-4179 | |
Mira Kheny, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1 Brace Rd Ste B2, Cherry Hill, NJ 08034 Phone: 856-354-2232 Fax: 856-375-6236 | |
Richard M Levine, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1 Brace Rd Ste B2, Cherry Hill, NJ 08034 Phone: 856-354-2232 Fax: 856-375-6236 | |
Stephanie Simonetti, APN Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 457 Haddonfield Rd Ste 110, Cherry Hill, NJ 08002 Phone: 844-542-2273 |